Preface<br>Section 1: Fatigue In Different Conditions and Scenarios<br>1. Fatigue in clinical conditions: Inflammatory bowel disease. A new narrative<br>2. Fatigue related to cancer treatments<br>3. Fatigue in systemic lupus erythematosus<br>4. Fatigue in patients with inflammatory rheumatic diseases<br>5. Fatigue in diverse groups: taxi drivers and beyond<br>6. Fatigue in clinical conditions: Sjogren's syndrome<br>7. Fatigue in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): linking in brain fog<br>8. Fatigue in fibromyalgia: a mental and physical context<br>9. Fatigue in chronic obstructive pulmonary disease (COPD)<br>10. Vocal fatigue<br>11. Work and fatigue in population cohorts: pilots<br>12. Fatigue and quality of life in Parkinson's disease<br>13. Fatigue in diabetes<br>14. Fatigue in stroke: a new narrative<br>15. Fatigue in COVID-19<br>Section 2: Mental Fatigue <br>16. Mental fatigue in the postpartum scenario<br>17. Features of mental fatigue in defined populations: subjects with psychiatric disease<br>18. Workplace measures of mental fatigue<br>19. Psychological perspective about mental fatigue: a focus on cognitive and motivational-affective abilities<br>20. Mental fatigue in infertility treatment<br>21. Psychosocial dimensions of mental fatigue<br>22. Fatigue and the reciprocal relationship with motor imagery<br>Section 3: Molecular And Cellular Aspects and Models<br>23. The role of glutathione in skeletal muscle fatigue<br>24. Muscular fatigue and molecular mechanisms: Tropomyosin receptor kinase B (TrkB) signaling<br>25. Fatigue in inflammatory bowel disease and the role of micronutrients<br>26. The mitochondria in fatigue syndromes<br>27. Fatigue and catalytic autoantibodies<br>28. Short chain fatty acids and fatigue<br>29. Investigating fatigue in rats on high-fat regimens<br>30. Computational modelling of fatigue<br>Section 4: Physiological Aspects<br>31. Temperature in the working environment and effects on fatigue<br>32. Mental imagery of fatigue-related multisensory sensations and fMRI<br>33. Fatigue of the respiratory muscles<br>34. Overview of cardiorespiratory system involvement in fatigue<br>35. Fatigue and physiology of exercise performance as a result of COVID-19<br>Section 5: Diagnosis and Assessments<br>36. Diagnosis and treatment of fatigue in Long COVID<br>37. Biomarkers, fatigue and long COVID<br>38. Questionnaires for screening fatigue: Parkinson's disease<br>Section 6: Treating and Managing Fatigue<br>39. Treating fatigue with dopaminergic regulators; a focus on s (-)-OSU6162 <br>40. Potential of using carnosine in ameliorating fatigue<br>41. Fatigue associated variables in multiple sclerosis and affective drug treatment<br>42. Modulating mental fatigue: use of Creatine, Caffeine or ketones<br>43. The Role of Bupropion in Managing Fatigue: Clinical Insights and Usage<br>44. The Mediterranean diet and effects on fatigue<br>45. Managing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a new narrative<br>46. Resistance training: features and use in treating fatigue in cancer survivors<br>47. Online treatment regimens in chronic fatigue syndrome<br>48. Omega-3 Polyunsaturated Fatty Acids in Fatigue Management: Clinical Applications and Mechanisms<br>Section 7: Resources<br>49. Resources for Fatigue